PK Parameters Explained: From Cmax to Clearance (and Why It Matters for Development Decisions)
Learn how key PK parameters such as Cmax, AUC, clearance, half life, and volume of…
CertaraApril 9, 2026
Integrated PK/PD Modeling and Machine Learning to Support CNS Compound Selection
PK/PD Modeling for CNS drug development using Phoenix NLME and machine learning for better CNS…
CertaraMarch 26, 2026
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Analysis for Clazakizumab in Patients With End-Stage Kidney Disease Undergoing Dialysis
This study evaluated the pharmacokinetics (PK) and pharmacokinetic–pharmacodynamic (PK–PD) relationship of clazakizumab, an anti–interleukin-6 (IL-6)…
Danielle PillsburyMarch 24, 2026
From Numbers to Narrative: Mastering the Art of PK Presentation
Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…
CertaraMarch 20, 2026
What are Common Bioequivalence Study Mistakes?
Learn about the most common bioequivalence study mistakes drug developers make and the differences between…
CertaraMarch 20, 2026
